Iavarone Michele, Rago Anna, Molinari Riccardo, D'Andrea Antonello, Nesti Martina, Muscoli Saverio, Mascia Giuseppe, Russo Vincenzo
Cardiology Unit, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", AORN Ospedali dei Colli Monaldi Hospital, 80131 Naples, Italy.
Unit of Cardiology and Intensive Coronary Care, Umberto I Hospital, 84014 Nocera Inferiore, Italy.
Rev Cardiovasc Med. 2023 May 19;24(5):152. doi: 10.31083/j.rcm2405152. eCollection 2023 May.
Sudden cardiac death (SCD) is one of the leading causes of cardiovascular death in general population. SCD primary prevention requires the correct selection of patients at increased risk who may benefit from implantable cardioverter-defibrillator (ICD). Despite several non-invasive arrhythmic risk indexes are available, their ability to stratify the SCD risk among asymptomatic patients with cardiac disease at increased arrhythmic risk is debated. The programmed ventricular stimulation (PVS) is an invasive approach historically used for SCD risk stratification in patients with acquired or inherited cardiac disease and is currently included in international guidelines. Aim of this review is to summarize all available data about the role of PVS for the SCD risk stratification in different clinical settings.
心脏性猝死(SCD)是普通人群心血管死亡的主要原因之一。SCD一级预防需要正确选择可能从植入式心脏复律除颤器(ICD)中获益的高危患者。尽管有几种非侵入性心律失常风险指数可用,但它们在对心律失常风险增加的无症状心脏病患者进行SCD风险分层的能力仍存在争议。程控心室刺激(PVS)是一种历史上用于获得性或遗传性心脏病患者SCD风险分层的侵入性方法,目前已被纳入国际指南。本综述的目的是总结关于PVS在不同临床环境中对SCD风险分层作用的所有现有数据。